Amrana Qureshi

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Real-world use of venetoclax in the treatment of paediatric and teenage/young adult haematological malignancies.

Real-world use of venetoclax in the treatment of paediatric and teenage/young adult haematological malignancies.

Journal: British journal of haematology

Published: August 05, 2024

Paediatric orbital lymphoma; a case series and review of the literature.

Paediatric orbital lymphoma; a case series and review of the literature.

Journal: Eye (London, England)

Published: February 28, 2022

Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill children.

Continuous intravenous anakinra for treating severe secondary haemophagocytic lymphohistiocytosis/macrophage activation syndrome in critically ill children.

Journal: Pediatric blood & cancer

Published: March 03, 2021

Effect of transfusion therapy on intracranial stenosis in a child with sickle cell anaemia.

Effect of transfusion therapy on intracranial stenosis in a child with sickle cell anaemia.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: January 30, 2021

The role of immunotherapy in relapse/refractory precursor-B acute lymphoblastic leukaemia: real-life UK/Ireland experience in children and young adults.

The role of immunotherapy in relapse/refractory precursor-B acute lymphoblastic leukaemia: real-life UK/Ireland experience in children and young adults.

Journal: British journal of haematology

Published: November 20, 2020

The Lazarus effect of very high-dose intravenous anakinra in severe non-familial CNS-HLH.

The Lazarus effect of very high-dose intravenous anakinra in severe non-familial CNS-HLH.

Journal: The Lancet. Rheumatology

Published: October 21, 2020

Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion.

Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion.

Journal: British journal of haematology

Published: July 24, 2020

"ITP" is not always immune thrombocytopenia.

"ITP" is not always immune thrombocytopenia.

Journal: American journal of hematology

Published: May 12, 2020

Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.

Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.

Journal: Leukemia

Published: March 08, 2019

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.

Journal: Leukemia

Published: June 03, 2018

Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline.

Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline.

Journal: British journal of haematology

Published: May 08, 2018

Transcranial Doppler screening for stroke risk in children with sickle cell disease: a systematic review.

Transcranial Doppler screening for stroke risk in children with sickle cell disease: a systematic review.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: April 26, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026